Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.1B | 6.8B | 6.4B | 5.9B |
Cost of revenue | 3.3B | 3.0B | 2.6B | 2.6B |
Gross profit | 3.8B | 3.8B | 3.8B | 3.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.6B | 1.6B | 1.6B | 1.2B |
Operating income | 1.0B | 1.2B | 1.2B | 1.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 34.4M | 26.7M | 26.3M | 29.2M |
Other income expense | — | — | — | — |
Pretax income | 1.2B | 1.4B | 1.2B | 1.2B |
Tax provision | 253.7M | 381.9M | 268.4M | 309.5M |
Net income | 907.3M | 1.1B | 977.6M | 890.7M |
Basic EPS | — | 2.3 | 2.1 | 2.0 |
Diluted EPS | — | 2.3 | 2.1 | 2.0 |
Basic average shares | — | 452.7M | 454.1M | 452.8M |
Diluted average shares | — | 452.7M | 454.1M | 452.8M |
EBITDA | 1.4B | 1.7B | 1.5B | 1.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | -1.8M | -5.0M | -10.4M | -3.2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |